Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Kolbjørn Forfang"'
Autor:
Reidar Bjørnerheim, Harald Arnesen, Ketil Lunde, Svein Solheim, Svend Aakhus, Kolbjørn Forfang, Ingebjørg Seljeflot
Publikováno v:
The American Journal of Cardiology. 106:1197-1200
The aim of the present study was to investigate the prevalence of left ventricular (LV) thrombus formation and important determinants in patients with acute ST elevation myocardial infarction localized to the anterior wall treated with percutaneous c
Autor:
Haakon K. Grøgaard, Ketil Lunde, Harald Arnesen, Ingebjørg Seljeflot, Arnfinn Ilebekk, Svein Solheim, Kolbjørn Forfang, Svend Aakhus
Publikováno v:
Scandinavian Cardiovascular Journal. 44:267-272
To examine the influence of intracoronary autologous bone marrow cell transplantation after acute myocardial infarction on circulating growth factors and their relationship to left ventricular function.Circulating insulin-like growth factor-1 (IGF-1)
Publikováno v:
Acta Medica Scandinavica. 219:47-52
In six patients with therapy-resistant cardiac edema, ultrafiltration on two consecutive days removed on an average 7750 ml fluid and reduced body weight by 7.3 kg. A difference between the mean ultrafiltration rate (17.4 ml/min) and the calculated p
Publikováno v:
Acta Medica Scandinavica. 212:131-136
Twelve patients with congestive heart failure were monitored with invasive and noninvasive techniques to evaluate the effect of vasodilator treatment. During the 18 hours of strict bed rest before administration of prazosin, the hemodynamics improved
Publikováno v:
Acta Medica Scandinavica. 210:149-152
Publikováno v:
Acta Medica Scandinavica. 194:563-566
Eight patients with severe chronic congestive heart failure (functional classes III-IV, N.Y.H.A.) have been treated with continuous infusion of glucagon (2–4 mg/h) for 96 hours. During this period all other treatment was kept constant. Mean b.wt. w
Autor:
Astami investigators, Svend Aakhus, Svein Solheim, Harald Arnesen, Kolbjørn Forfang, Michael Abdelnoor, Ketil Lunde
Publikováno v:
Scandinavian Cardiovascular Journal. 39:150-158
Intracoronary transplantation of different cell populations has been used in acute myocardial infarction (AMI) with promising results. The primary objective of the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) study is
Autor:
Kjell Rootwelt, Svein Blomhoff, Kjell Saatvedt, Kolbjørn Forfang, Lars Aaberge, Michel Abdelnoor
Publikováno v:
Journal of the American College of Cardiology. 39:1588-1593
Objectives The goals of this study were to assess late clinical outcome and left ventricular ejection fraction (LVEF) after transmyocardial revascularization with CO2laser (TMR). Background During the 1990s TMR emerged as a treatment option for patie
Publikováno v:
Journal of Clinical Oncology. 19:3226-3233
PURPOSE: Long-term medical complications, such as cardiac, pulmonary, and thyroid dysfunction, are frequent among Hodgkin’s disease survivors (HDSs). Chronic fatigue is also highly prevalent among HDSs. Few studies have explored possible etiologic
Autor:
Lorentz Brinch, Svend Aakhus, Kolbjørn Forfang, Svein Solheim, Torstein Egeland, Asgrimur Ragnarsson, Arild Mangschau, Reidar Bjørnerheim, Arnfinn Ilebekk, Harald Arnesen, Ketil Lunde, Knut Endresen
Publikováno v:
Journal of the American College of Cardiology. 51:674-676
To the Editor: Intracoronary injection of bone marrow cells (BMC) has been introduced for improvement of left ventricular (LV) function after acute myocardial infarction (AMI). In the randomized ASTAMI (Autologous Stem cell Transplantation in Acute M